4.8000
-0.3000
(-5.88%)
At close: January 10 at 3:29:02 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 3 | 6 | 7 |
| Avg. Estimate | -- | -- | -- | 1.43M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 10M |
| Year Ago Sales | -- | -- | 2M | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | -100.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0O2.F | -- | -- | -- | -- |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
| Initiated | Oppenheimer: Outperform | 12/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/15/2024 |
| Initiated | UBS: Buy | 11/12/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/31/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/2/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 8/15/2024 |
Related Tickers
GX1.F Marker Therapeutics, Inc.
2.6200
0.00%
UTH.F United Therapeutics Corporation
352.30
-0.03%
0A9E.IL CureVac N.V.
4.3740
+1.37%
347850.KQ D&D Pharmatech
53,900.00
-3.92%
MRZM Marizyme, Inc.
0.0041
-14.58%
MAAT.PA MaaT Pharma SA
7.92
-12.78%
NVV1.F Novavax, Inc.
8.89
-6.92%
0QF.DE Moderna, Inc.
41.54
-1.11%
DMYD-B.ST Diamyd Medical AB (publ)
17.14
-5.20%
5CV.F CureVac N.V.
4.1500
+4.27%